Company Filing History:
Years Active: 2010
Title: Andrew Grupe: Innovator in Neurodegenerative Disease Research
Introduction
Andrew Grupe is a notable inventor based in Orinda, CA (US). He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of 3 patents, Grupe's work focuses on genetic polymorphisms associated with conditions such as Alzheimer's and Parkinson's diseases.
Latest Patents
Grupe's latest patents include groundbreaking discoveries related to genetic polymorphisms associated with neurodegenerative diseases. One of his patents, titled "Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof," outlines the discovery of specific genetic variations linked to Alzheimer's and Parkinson's diseases. This invention encompasses nucleic acid molecules containing these polymorphisms, variant proteins encoded by such molecules, and reagents for their detection. Another patent, "Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof," further explores similar genetic variations specifically related to Alzheimer's Disease, detailing methods for using these nucleic acids and proteins in detection processes.
Career Highlights
Andrew Grupe is currently associated with Celera Corporation, where he continues to advance research in genetics and neurodegenerative diseases. His work has been instrumental in understanding the genetic factors that contribute to these debilitating conditions.
Collaborations
Grupe collaborates with various professionals in his field, including his coworker Yonghong Li, to enhance the impact of his research and inventions.
Conclusion
Andrew Grupe's innovative contributions to the understanding of neurodegenerative diseases through his patents highlight the importance of genetic research in medical science. His work continues to pave the way for advancements in detection and treatment methods for these conditions.